New Alzheimerâs drugs bring hope. But not equally for all patients

Subjects :: United States. Food and Drug Administration -- Powers and duties
Testing
Powers and duties
Care and treatment
Demographic aspects
Health aspects
Product development
Anti-Alzheimer's disease agents -- Product development -- Testing
Clinical trials -- Demographic aspects
Black people -- Health aspects
Alzheimer's disease -- Care and treatment
Alzheimer's disease -- Drug therapy -- Care and treatment
Blacks -- Health aspects

Tools